- Accesswire•6 days agoResearch Reports Initiated on Healthcare Stocks Immunovaccine, IntelliPharmaCeutics International, Cardiome Pharma, and Aeterna Zentaris
LONDON, UK / ACCESSWIRE / January 12, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected ...
- GlobeNewswire•12 days agoIntellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical
TORONTO, Jan. 06, 2017-- Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release ...
- GlobeNewswire•20 days ago
TORONTO, Dec. 29, 2016-- Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release ...
I.TO : Summary for INTELLIPHARMACEUTICS INTERNATIO - Yahoo Finance
IntelliPharmaCeutics International Inc. (I.TO)
Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
|Day's Range||3.27 - 3.40|
|52 Week Range||1.78 - 4.50|
|PE Ratio (TTM)||-8.91|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|